Jyothy Labs License Agreement for Pril and Fa Brands Set to Conclude

Jyothy Labs has announced that the license and technology agreements for the Pril and Fa brands will not be renewed beyond May 31, 2026. Following unsuccessful discussions with Henkel AG & Co. KGaA, the company is now evaluating the financial impact of the discontinuation of these brands. The board of directors is currently reviewing all available options to mitigate the transition as the company prepares for the conclusion of these longstanding manufacturing and distribution arrangements.

Agreement Expiry Details

Jyothy Labs has confirmed that the existing license agreements, originally entered into on May 31, 2011, for the manufacturing, distribution, marketing, and sale of the Pril and Fa brands, will reach their final term on May 31, 2026. Despite engaging in discussions regarding potential renewals, the company and its partner, Henkel AG & Co. KGaA, have concluded that there is no further possibility of continuing the partnership for these specific brands.

Strategic Evaluation and Next Steps

The company held a board meeting to address the implications of this development. Jyothy Labs is currently in the process of assessing the total financial impact of the non-renewal. Because the original agreements included provisions for brand valuation and transfer mechanisms in the event of business discontinuation, management is evaluating all available options to protect shareholder interests. Further material updates regarding the transition will be communicated as the company finalizes its strategy.

Source: BSE

Previous Article

PNC Infratech Limited Board Meeting Scheduled for May 19, 2026

Next Article

Alembic Pharmaceuticals Annual Secretarial Compliance Report for FY 2026